Global and Japan Herpes Marker Testing Market Size, Status and Forecast 2021-2027

Herpes marker testing is done to detect the presence of the herpes simplex virus (HSV) infection in the body. Various strains of herpes simplex virus have been known to infect humans. Among these, only two are included in the scope of our study: HSV1 and HSV-2. HSV-1 generally causes orofacial diseases such as cold sores, whereas HSV-2 is responsible only for genital herpes. Diagnostic kits available for herpes marker testing include HSV-1 kits, HSV-2 kits and HSV-1/HSV-2 kits.

Market Analysis and Insights: Global Herpes Marker Testing Market
The global Herpes Marker Testing market size is projected to reach US$ 93 million by 2027, from US$ 74 million in 2020, at a CAGR of 3.3% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Herpes Marker Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Herpes Marker Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Herpes Marker Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Herpes Marker Testing market.

Global Herpes Marker Testing Scope and Market Size
Herpes Marker Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Herpes Marker Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
HSV-1
HSV-2
HSV-1/ HSV-2

Segment by Application
Research
Clinic

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Abcam Plc
BioMérieux SA
Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd.
DiaSorin S.p.A.
Quidel Corporation
Luminex Corporation
Merck KGaA
Qiagen N.V.
Norgen Biotek Corp.
Hologic Inc.
Bio Rad Laboratories Inc.
Meridian Bioscience Inc
Teco Diagnostics